IL-6 high Median (range) [pg/mL] | Rb | Pb | IL-6 low Median (range) [pg/mL] | Rb | Pb | IL-8 high Median (range) [pg/mL] | Rb | Pb | IL-8 low Median (range) [pg/mL] | Rb | Pb | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Gendera | ||||||||||||
Female (n = 10) | 13.3 (9.8–16.0) | – | – | 1.2 (0–5.0) | – | – | 65.8 (41.4–147.1) | – | – | 12.9 (2.6–25.9) | – | – |
Male (n = 7) | 93.1 (6.8–580.1) | – | – | 1.7 (0–3.6) | – | – | 85.3 (34.1–285.1) | – | – | 7.5 (3.3–19.6) | – | – |
Age, years | ||||||||||||
< 40 (n = 11) | 13.3 (6.8–580.1) | 0.39 | 0.38 | 2.7 (0–5.0) | - 0.20 | 0.80 | 73.0 (34.1–147.1) | 0.71 | 0.11 | 19.6 (34.1–147.1) | 0.40 | 0.50 |
≥ 40 (n = 6) | 17.6 (16.0–19.2) | c | c | 0.73 (0–2.9) | 0.31 | 0.54 | 126.1 (41.4–285.1) | - 0.50 | 0.66 | 6.9 (2.6–20.8) | 0.60 | 0.28 |
Leukocyte counts, × 109/L | ||||||||||||
< 10 (n = 11) | 13.3 (6.8–580.1) | - 0.63 | 0.12 | 2.3 (0–5.0) | - 0.31 | 0.54 | 66.5 (34.1–285.1) | - 0.25 | 0.58 | 13.6 (3.3–25.9) | - 0.82 | 0.04* |
≥ 10 (n = 6) | 93.1 (19.2–167.0) | c | c | 0.8 (0–1.8) | 0.91 | 0.25 | 102.8 (79.6–126.1) | c | c | 12.9 (2.6–20.8) | 0.50 | 0.66 |
Platelet counts, × 109/L | ||||||||||||
< 40 (n = 10) | 14.2 (6.8–580.1) | 0.80 | 0.10 | 0.9 (0–5.0) | 0.52 | 0.28 | 105.7 (34.1–147.1) | 0.40 | 0.60 | 6.9 (2.6–25.9) | 0.32 | 0.47 |
≥ 40 (n = 7) | 14.7 (9.8–167.0) | - 0.21 | 0.78 | 0.8 (0.6–1.8) | - 0.50 | 0.66 | 65.8 (41.4–79.6) | - 0.63 | 0.36 | 12.9 (7.5–20.8) | 0.50 | 0.66 |
Relapse-risk groupe,a | ||||||||||||
Low/Intermediate (n = 11) | 13.3 (6.8–580.1) | – | – | 2.3 (0–5.0) | – | – | 66.5 (34.1–285.1) | – | – | 13.6 (3.3–25.9) | – | – |
High (n = 6) | 93.1 (19.2–167.0) | – | – | 0.8 (0–1.8) | – | – | 102.8 (79.6–126.1 | – | – | 12.9 (2.6–20.8) | – | – |
Death during inductiond | ||||||||||||
Yes (n = 2) | 167.0 (167.0) | – | – | 0.8 (0.8) | – | – | 79.6 (79.6) | – | – | 20.8 (20.8) | – | – |
No (n = 15) | 13.8 (6.8–580.1) | 1.76 (0–5.0) | 75.9 (34.1–285.1) | 7.5 (2.6–25.9) |